Sinopharm applies for vaccine market approval
chinadaily.com.cn |
Updated: 2020-11-25 14:29
Share
Share - WeChat
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.
- AI empowers culture and museum sector
- Shaanxi strengthens intellectual property protection, officials say
- 29th Shandong-Taiwan Economic and Trade Fair to facilitate cross-Strait talent recognition
- World's highest bridge passes crucial load test
- Nobel laureate partners with Shanghai Henlius Biotech for immunotherapy clinical trials
- Beluga whales witness 'Deep Sea Certification' wedding in Heilongjiang
